Voyageur Pharmaceuticals Ltd.

TSXV:VM Stock Report

Market Cap: CA$9.1m

Voyageur Pharmaceuticals Management

Management criteria checks 2/4

Voyageur Pharmaceuticals' CEO is Brent Willis, appointed in Jul 2019, has a tenure of 5.33 years. total yearly compensation is CA$132.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 4.95% of the company’s shares, worth CA$448.77K. The average tenure of the management team and the board of directors is 3.8 years and 2.2 years respectively.

Key information

Brent Willis

Chief executive officer

CA$132.0k

Total compensation

CEO salary percentage100.0%
CEO tenure5.3yrs
CEO ownership5.0%
Management average tenure3.8yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Have Insiders Been Buying Voyageur Pharmaceuticals Ltd. (CVE:VM) Shares?

Dec 18
Have Insiders Been Buying Voyageur Pharmaceuticals Ltd. (CVE:VM) Shares?

CEO Compensation Analysis

How has Brent Willis's remuneration changed compared to Voyageur Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2024n/an/a

-CA$2m

May 31 2024n/an/a

-CA$1m

Feb 29 2024n/an/a

-CA$1m

Nov 30 2023CA$132kCA$132k

-CA$1m

Aug 31 2023n/an/a

-CA$2m

May 31 2023n/an/a

-CA$2m

Feb 28 2023n/an/a

-CA$2m

Nov 30 2022CA$131kCA$131k

-CA$2m

Aug 31 2022n/an/a

-CA$2m

May 31 2022n/an/a

-CA$2m

Feb 28 2022n/an/a

-CA$2m

Nov 30 2021CA$110kCA$110k

-CA$2m

Aug 31 2021n/an/a

-CA$2m

May 31 2021n/an/a

-CA$853k

Feb 28 2021n/an/a

-CA$820k

Nov 30 2020CA$43kCA$43k

-CA$1m

Aug 31 2020n/an/a

-CA$1m

May 31 2020n/an/a

-CA$999k

Feb 29 2020n/an/a

-CA$817k

Nov 30 2019CA$63kCA$63k

-CA$552k

Aug 31 2019n/an/a

-CA$798k

May 31 2019n/an/a

-CA$511k

Feb 28 2019n/an/a

-CA$558k

Nov 30 2018CA$60kCA$60k

-CA$556k

Aug 31 2018n/an/a

-CA$359k

May 31 2018n/an/a

-CA$637k

Feb 28 2018n/an/a

-CA$767k

Nov 30 2017CA$65kCA$60k

-CA$671k

Compensation vs Market: Brent's total compensation ($USD93.89K) is below average for companies of similar size in the Canadian market ($USD171.43K).

Compensation vs Earnings: Brent's compensation has increased whilst the company is unprofitable.

CEO

Brent Willis (53 yo)

5.3yrs

Tenure

CA$132,000

Compensation

Mr. Brent Willis, Bsc. Eng., serves as President of Voyageur Pharmaceuticals Ltd. (formerly known as Voyageur Minerals Ltd.) since July 1, 2019 and serves as its Director since October 30, 2017. Mr. Willis...

Leadership Team

NamePositionTenureCompensationOwnership
Brent Willis
President5.3yrsCA$132.00k4.95%
CA$ 448.8k
Bradley Willis
Founder10.2yrsCA$126.00k4.86%
CA$ 440.6k
Albert Deslauriers
Chief Financial Officer2.3yrsCA$105.60kno data
Ethan Mohan
Sales Managerless than a yearno datano data

3.8yrs

Average Tenure

Experienced Management: VM's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Brent Willis
President7.1yrsCA$132.00k4.95%
CA$ 448.8k
Bradley Willis
Founder5.2yrsCA$126.00k4.86%
CA$ 440.6k
Agustin Gago
Directorless than a yearCA$6.00kno data
Ralph Hesje
Independent Director3.3yrsCA$40.90kno data
Eric Pommer
Independent Director2.2yrsCA$15.00kno data
Eugene Fritzel
Independent Director2.2yrsCA$13.00kno data
Alec Megibow
Member of Scientific Advisory Boardno datano datano data
Deborah Baumgarten
Member of Scientific Advisory Boardno datano datano data
C. Johnson
Member of Scientific Advisory Boardno datano datano data
Sat Somers
Member of Scientific Advisory Boardno datano datano data
Thomas Lauenstein
Member of Scientific Advisory Boardno datano datano data
Kevin McBeth
Director1.3yrsCA$5.50kno data

2.2yrs

Average Tenure

58.5yo

Average Age

Experienced Board: VM's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.